Position in KYMR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$43,378,053
+$19,272,596 QoQ
Shares Held
378,286
+30.7% QoQ
Ownership
0.455%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 275 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. KYMR ranks #54 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in KYMR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,378,053 | 378,286 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $24,105,457 | 289,416 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $26,377,509 | 338,999 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $10,541,975 | 186,254 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $5,888,736 | 134,939 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,649,551 | 96,805 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,504,719 | 62,260 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,255,142 | 111,032 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,513,049 | 151,191 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,524,095 | 162,291 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $763,747 | 29,998 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,232,441 | 88,665 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,219,148 | 140,024 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $8,201,227 | 276,788 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,163,797 | 206,883 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $2,733,787 | 125,576 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,345,333 | 119,113 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,469,350 | 129,238 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,597,944 | 72,420 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,114,991 | 36,006 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $405,071 | 8,352 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $1,257,313 | 32,355 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $235,848 | 3,804 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $79,062 | 2,447 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||